Search Results - "CASTELLINO, Claudia"

Stem cell collection and hematological recovery in the Fondazione Italiana Linfomi (FIL) MCL0208 clinical trial by Clerico, Michele, Ferrero, Simone, Alessandria, Beatrice, Zaccaria, Gian Maria, Genuardi, Elisa, Ragaini, Simone, Tavarozzi, Rita, Cavallo, Federica, Hohaus, Stefan, Musuraca, Gerardo, Carella, Angelo Michele, Stelitano, Caterina, Tani, Monica, Gaidano, Gianluca, Olivieri, Jacopo, Usai, Sara Veronica, Galimberti, Sara, Re, Francesca, Mian, Michael, Castellino, Claudia, Pavone, Vincenzo, Evangelista, Andrea, Bruno, Benedetto, Cortelazzo, Sergio, Passera, Roberto, Ladetto, Marco

“…In the frontline high-dose phase 3 FIL-MCL0208 trial (NCT02354313), 8% of enrolled mantle cell lymphoma (MCL) patients could not be randomised to receive…”
Get full text

Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial by Bruna, Riccardo, Benedetti, Fabio, Boccomini, Carola, Patti, Caterina, Barbui, Anna Maria, Pulsoni, Alessandro, Musso, Maurizio, Liberati, Anna Marina, Gini, Guido, Castellino, Claudia, Rossini, Fausto, Ciceri, Fabio, Rota-Scalabrini, Delia, Stelitano, Caterina, Di Raimondo, Francesco, Tucci, Alessandra, Devizzi, Liliana, Zoli, Valerio, Zallio, Francesco, Narni, Franco, Dondi, Alessandra, Parvis, Guido, Semenzato, Gianpietro, Lanza, Francesco, Perrone, Tommasina, Angrilli, Francesco, Billio, Atto, Gueli, Angela, Mantoan, Barbara, Rambaldi, Alessandro, Gianni, Alessandro Massimo, Corradini, Paolo, Passera, Roberto, Ladetto, Marco, Tarella, Corrado

“…A prospective trial conducted in the period 2000-2005 showed no survival advantage for high-dose chemotherapy with rituximab and autograft (R-HDS) conventional…”
Get full text

Rituximab Maintenance Compared With Observation After Brief First-Line R-FND Chemoimmunotherapy With Rituximab Consolidation in Patients Age Older Than 60 Years With Advanced Follicular Lymphoma: A Phase III Randomized Study by the Fondazione Italiana Linfomi by VITOLO, Umberto, LADETTO, Marco, DE RENZO, Amalia, ZAJA, Francesco, CASTELLINO, Claudia, BARI, Alessia, ALVAREZ DE CELIS, Isabel, EVANGELISTA, Andrea, PARVIS, Guido, GAMBA, Enrica, LOBETTI-BODONI, Chiara, CICCONE, Giovannino, BOCCOMINI, Carola, ROSSI, Giuseppe, BALDINI, Luca, DEANGELIS, Federico, TUCCI, Alessandra, BOTTO, Barbara, CHIAPPELLA, Annalisa, CHIARENZA, Annalisa, PINTO, Antonello

“…To evaluate the efficacy of rituximab maintenance in 60- to 75-year-old patients with advanced follicular lymphoma responding to brief first-line…”
Get full text

Immunoglobulin M (IgM) multiple myeloma versus Waldenström macroglobulinemia: diagnostic challenges and therapeutic options: two case reports by Elba, Simona, Castellino, Alessia, Soriasio, Roberto, Castellino, Claudia, Bonferroni, Margherita, Mattei, Daniele, Strola, Giuliana, Drandi, Daniela, Mordini, Nicola, Foglietta, Miriam, Rapezzi, Davide, Celeghini, Ivana, Grasso, Mariella, Giordano, Fabrizio, Fraternali Orcioni, Giulio, Massaia, Massimo

“…Immunoglobulin M multiple myeloma and Waldenström macroglobulinemia are two different hematological diseases with the common finding of an immunoglobulin M…”
Get full text

Diagnosis of maternal Hodgkin lymphoma following abnormal findings at noninvasive prenatal screening test (NIPT): Report of two cases by Castellino, Alessia, Elba, Simona, Sorasio, Roberto, Castellino, Claudia, Bonferroni, Margherita, Grasso, Mariella, Grosso, Enrico, Giacchello, Rosalba, Signorile, Anna Franca, Celeghini, Ivana, Mattei, Daniele, Mordini, Nicola, Foglietta, Myriam, Masturzo, Bianca, Priotto, Roberto, Zonta, Andrea, Rapezzi, Davide, Massaia, Massimo

“…Abnormal NIPT results, contrasting with normal fetus development, could disclose maternal malignancy, and this possibility should always be explained during…”
Get full text

Peripheral Blood CD34+ Percentage at Hematological Recovery after Chemotherapy Is a Good Early Predictor of Harvest: A Single-Center Experience by Sorasio, Roberto, Bonferroni, Margherita, Grasso, Mariella, Strola, Giuliana, Rapezzi, Davide, Marenchino, Dario, Di Marco, Cristina, Castellino, Claudia, Mattei, Daniele, Mordini, Nicola, Fiore, Francesca, Celeghini, Ivana, Borra, Anna, Ghiglia, Annalisa, Gallamini, Andrea

“…Abstract Several algorithms for early prediction of poor-mobilizing patients after chemotherapy and granulocyte colony-stimulating factor administration have…”
Get full text

Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphoma by Ferrero, Simone, Grimaldi, Daniele, Genuardi, Elisa, Drandi, Daniela, Zaccaria, Gian Maria, Alessandria, Beatrice, Ghislieri, Marco, Ferrante, Martina, Evangelista, Andrea, Mantoan, Barbara, De Luca, Gabriele, Stefani, Piero Maria, Benedetti, Fabio, Casaroli, Ivana, Zanni, Manuela, Castellino, Claudia, Pavone, Vincenzo, Petrini, Mario, Re, Francesca, Hohaus, Stefan, Musuraca, Gerardo, Cascavilla, Nicola, Ghiggi, Chiara, Liberati, Anna Marina, Cortelazzo, Sergio, Ladetto, Marco

“…Minimal residual disease (MRD) analysis is a known predictive tool in mantle cell lymphoma (MCL). We describe MRD results from the Fondazione Italiana Linfomi…”
Get full text

Prognostic Impact of Pre-Treatment Cell-Free DNA Concentration in Newly Diagnosed Peripheral T-Cell Lymphomas by Fardella, Eugenio, Zanirato, Giada, Magni, Martina, Caldarelli, Nicole, Chiappella, Annalisa, Dodero, Anna, Ljevar, Silva, Orsucci, Lorella, Re, Alessandro, Usai, Sara, Stefoni, Vittorio, Castellino, Claudia, Rossi, Francesca Gaia, Pinto, Antonio, Carniti, Cristiana, Corradini, Paolo

“…Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of non-Hodgkin lymphomas with poor prognosis. Although some risk factors associated with worse…”
Get full text

RE-MIND: Comparing Tafasitamab + Lenalidomide (L-MIND) with a Real-world Lenalidomide Monotherapy Cohort in Relapsed or Refractory Diffuse Large B-cell Lymphoma by Zinzani, Pier Luigi, Rodgers, Thomas, Marino, Dario, Frezzato, Maurizio, Barbui, Anna Maria, Castellino, Claudia, Meli, Erika, Fowler, Nathan H, Salles, Gilles, Feinberg, Bruce, Kurukulasuriya, Nuwan C, Tillmanns, Sascha, Parche, Stephan, Dey, Debarshi, Fingerle-Rowson, Günter, Ambarkhane, Sumeet, Winderlich, Mark, Nowakowski, Grzegorz S

“…Tafasitamab, an Fc-modified, humanized, anti-CD19 monoclonal antibody, in combination with lenalidomide, demonstrated efficacy in transplant-ineligible…”
Get full text

Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study by Chiappella, Annalisa, Dodero, Anna, Evangelista, Andrea, Re, Alessandro, Orsucci, Lorella, Usai, Sara Veronica, Castellino, Claudia, Stefoni, Vittorio, Pinto, Antonio, Zanni, Manuela, Ciancia, Rosanna, Ghiggi, Chiara, Rossi, Francesca Gaia, Arcari, Annalisa, Ilariucci, Fiorella, Zilioli, Vittorio Ruggero, Flenghi, Leonardo, Celli, Melania, Volpetti, Stefano, Benedetti, Fabio, Ballerini, Filippo, Musuraca, Gerardo, Bruna, Riccardo, Patti, Caterina, Leonardi, Francesco, Arcaini, Luca, Magagnoli, Massimo, Cavallo, Federica, Bermema, Anisa, Tucci, Alessandra, Boccomini, Carola, Ciccone, Giovannino, Carniti, Cristiana, Pileri, Stefano Aldo, Corradini, Paolo

“…The standard treatment for young patients with untreated PTCLs is based on anthracycline containing-regimens followed by high-dose-chemotherapy and…”
Get full text

Outcome of follicular lymphoma (FL) patients in maintenance with antiCD20 monoclonal antibodies (MoAb) in SARS-Cov2 era by Castellino, Alessia, Castellino, Claudia, Boccomini, Carola, Clerico, Michele, Nicoli, Paolo, Vanazzi, Anna, Fanelli, Fulvia, Perrone, Tommasina, Marchesi, Francesco, Cocito, Federica, Merli, Michele, Bigliardi, Sara, Mecacci, Bianca, Bozzoli, Valentina, Margiotta-Casaluci, Gloria, Meli, Erika, Anastasia, Antonella, Farina, Lucia, Annibali, Ombretta, Massaia, Massimo

“…e19544 Background: Maintenance in FL patients (pts) improves progression free survival (PFS). SARS-Cov2 pandemic posed unique challenges for immunocompromised…”
Get full text

Randomized Trial Comparing R-CHOP Versus High-Dose Sequential Chemotherapy in High-Risk Patients With Diffuse Large B-Cell Lymphomas by Cortelazzo, Sergio, Tarella, Corrado, Gianni, Alessandro Massimo, Ladetto, Marco, Barbui, Anna Maria, Rossi, Andrea, Gritti, Giuseppe, Corradini, Paolo, Di Nicola, Massimo, Patti, Caterina, Mulé, Antonino, Zanni, Manuela, Zoli, Valerio, Billio, Atto, Piccin, Andrea, Negri, Giovanni, Castellino, Claudia, Di Raimondo, Francesco, Ferreri, Andrés J M, Benedetti, Fabio, La Nasa, Giorgio, Gini, Guido, Trentin, Livio, Frezzato, Maurizio, Flenghi, Leonardo, Falorio, Simona, Chilosi, Marco, Bruna, Riccardo, Tabanelli, Valentina, Pileri, Stefano, Masciulli, Arianna, Delaini, Federica, Boschini, Cristina, Rambaldi, Alessandro

“…Purpose The benefit of high-dose chemotherapy with autologous stem-cell transplantation (ASCT) as first-line treatment in patients with diffuse large B-cell…”
Get full text

Rituximab and Lenalidomide (R 2) Vs Rituximab Alone As Maintenance Treatment after Chemoimmunotherapy for Elderly Patients with Relapsed/Refractory Follicular Lymphoma (FL): Final Analysis of Renoir Phase III Study of the Fondazione Italiana Linfomi (FIL) by Boccomini, Carola, Botto, Barbara, Evangelista, Andrea, Zilioli, Vittorio Ruggero, Anastasia, Antonella, Cavallo, Federica, Merli, Francesco, Zanni, Manuela, Tani, Monica, Chiarenza, Annalisa, Liberati, Anna Marina, Conconi, Annarita, Corradini, Paolo, Bari, Alessia, Annechini, Giorgia, Gaidano, Gianluca, Spina, Michele, Sartori, Roberto, Castellino, Claudia, Puccini, Benedetta, Arcari, Annalisa, Bigliardi, Sara, Matta, Giorgia, Merli, Michele, Mannina, Donato, Marino, Dario, Galieni, Piero, Ciambelli, Fabrizio, Musuraca, Gerardo, Bottelli, Chiara, Muzi, Cristina, Ferrero, Simone, Luminari, Stefano, Ladetto, Marco, Ciccone, Giovannino, Vitolo, Umberto

“…Background: Elderly patients with relapsed/refractory (R/R) FL have limited treatment options. Lenalidomide has direct tumoricidal and antiangiogenetic actions…”
Get full text

O17-2 Tafasitamab + lenalidomide versus lenalidomide monotherapy in transplant-ineligible patients with R/R DLBCL (RE-MIND) by Nowakowski, Grzegorz, Rodgers, Thomas, Marino, Dario, Frezzato, Maurizio, Barbui, Anna Maria, Castellino, Claudia, Meli, Erika, Fowler, Nathan H., Feinberg, Bruce, Tillmanns, Sascha, Parche, Stephan, Fingerle-Rowson, Gunter, Winderlich, Mark, Ambarkhane, Sumeet, Salles, Gilles, Zinzani, Pier Luigi

Get full text

Rituximab, Bendamustine and Cytarabine Followed By Venetoclax (V-RBAC) in High-Risk Older Patients with Mantle Cell Lymphoma: A Phase 2 Study By the Fondazione Italiana Linfomi (FIL) by Visco, Carlo, Tabanelli, Valentina, Sacchi, Maria Vittoria, Evangelista, Andrea, Ferrarini, Isacco, Tisi, Maria Chiara, Merli, Anna, Fiori, Stefano, Zilioli, Vittorio Ruggero, Re, Alessandro, Castellino, Claudia, Piazza, Francesco, Corradini, Paolo, Hohaus, Stefan, Musuraca, Gerardo, Rossi, Francesca Gaia, Puccini, Benedetta, Cavallo, Federica, Ballerini, Filippo, Sciarra, Roberta, Di Rocco, Alice, Arcari, Annalisa, Boccomini, Carola, Merli, Francesco, Gini, Guido, Tani, Monica, Bruna, Riccardo, Pavone, Vincenzo, Ferreri, Andrés José María, Santoro, Armando, Patti, Caterina, Loseto, Giacomo, Ladetto, Marco, Merli, Michele, Spina, Michele, Zinzani, Pier Luigi, Stefani, Piero Maria, Usai, Sara, Pileri, Stefano, Balzarotti, Monica

“…Introduction: The R-BAC regimen is considered among standard first-line treatments for elderly fit patients with mantle cell lymphoma (MCL). We previously…”
Get full text

The Addition of Romidepsin to CHOEP and High-Dose Chemotherapy Plus Stem Cell Transplantation Did Not Ameliorate the Outcome of Untreated Angioimmunoblastic T-Cell or Follicular T-Helper Lymphoma: Subgroup Analysis of Phase II FIL-PTCL13 Study by Chiappella, Annalisa, Dodero, Anna, Evangelista, Andrea, Re, Alessandro, Orsucci, Lorella, Usai, Sara Veronica, Castellino, Claudia, Stefoni, Vittorio, Pinto, Antonio, Zanni, Manuela, Ciancia, Rosanna, Ghiggi, Chiara, Rossi, Francesca Gaia, Arcari, Annalisa, Ilariucci, Fiorella, Zilioli, Vittorio Ruggero, Flenghi, Leonardo, Celli, Melania, Volpetti, Stefano, Benedetti, Fabio, Ballerini, Filippo, Musuraca, Gerardo, Bruna, Riccardo, Patti, Caterina, Leonardi, Francesco, Arcaini, Luca, Magagnoli, Massimo, Cavallo, Federica, Tabanelli, Valentina, Ciccone, Giovannino, Pileri, Stefano A, Corradini, Paolo

Get full text

RE-MIND study: A propensity score-based 1:1 matched comparison of tafasitamab + lenalidomide (L-MIND) versus lenalidomide monotherapy (real-world data) in transplant-ineligible patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) by Nowakowski, Grzegorz S., Rodgers, Thomas David, Marino, Dario, Frezzato, Maurizio, Barbui, Anna Maria, Castellino, Claudia, Meli, Erika, Fowler, Nathan Hale, Feinberg, Bruce A., Tillmanns, Sascha, Parche, Stephan, Fingerle-Rowson, Guenter, Winderlich, Mark, Ambarkhane, Sumeet Vijay, Salles, Gilles A., Zinzani, Pier Luigi

“…Abstract only 8020 Background: Patients with R/R DLBCL ineligible for autologous stem cell transplant (ASCT) have a poor prognosis. In these patients,…”
Get full text

Lenalidomide in Pretreated Patients with Diffuse Large B‐Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice by Broccoli, Alessandro, Casadei, Beatrice, Chiappella, Annalisa, Visco, Carlo, Tani, Monica, Cascavilla, Nicola, Conconi, Annarita, Balzarotti, Monica, Cox, Maria Christina, Marino, Dario, Goldaniga, Maria Cecilia, Marasca, Roberto, Tecchio, Cristina, Patti, Caterina, Musuraca, Gerardo, Devizzi, Liliana, Monaco, Federico, Romano, Alessandra, Fama, Angelo, Zancanella, Michelle, Paolini, Rossella, Rigacci, Luigi, Castellino, Claudia, Gaudio, Francesco, Argnani, Lisa, Zinzani, Pier Luigi

“…Background Diffuse large B‐cell lymphoma (DLBCL) is the most common non‐Hodgkin lymphoma subtype, and approximately 50% of the patients are >60 years of age…”
Get full text

Adding Romidepsin to CHOEP in First Line Treatment of Peripheral T-Cell Lymphomas Does Not Improve the Response Rate: Final Analysis of Phase II PTCL13 Study by Chiappella, Annalisa, Carniti, Cristiana, Re, Alessandro, Castellino, Claudia, Evangelista, Andrea, Tabanelli, Valentina, Ciancia, Rosanna, Orsucci, Lorella, Pinto, Antonello, Usai, Sara Veronica, Arcari, Annalisa, Ilariucci, Fiorella, Rossi, Francesca Gaia, Benedetti, Fabio, Flenghi, Leonardo, Ghiggi, Chiara, Molinari, Anna Lia, Stefoni, Vittorio, Volpetti, Stefano, Zilioli, Vittorio Ruggero, Ballerini, Filippo, Bruna, Riccardo, Cavallo, Federica, Musuraca, Gerardo, Patti, Caterina, Re, Francesca, Tani, Monica, Varettoni, Marzia, Zanni, Manuela, Dodero, Anna, Pileri, Stefano A, Ciccone, Giovannino, Corradini, Paolo

“…Introduction: Peripheral T-cell lymphomas (PTCL) have a 40-50% cure rate when treated with cyclophosphamide-doxorubicin-etoposide-vincristine-prednisone…”
Get full text

Upfront intensive chemo-immunotherapy with autograft in 199 adult mantle cell lymphoma patients: prolonged survival and cure potentiality at long term by Cortelazzo, Sergio, Mian, Michael, Evangelista, Andrea, Devizzi, Liliana, Corradini, Paolo, Magni, Michele, Ladetto, Marco, Ferrero, Simone, Rossi, Andrea, Barbui, Anna Maria, Patti, Caterina, Costa, Alessandro, Vitolo, Umberto, Chiappella, Annalisa, Benedetti, Fabio, Ferreri, Andrés J. M., Nicoli, Paolo, Rigacci, Luigi, Castellino, Claudia, Gianni, Alessandro M., Rambaldi, Alessandro, Tarella, Corrado

Get full text